BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schroen B, Heymans S. MicroRNAs and beyond: the heart reveals its treasures. Hypertension. 2009;54:1189-1194. [PMID: 19841290 DOI: 10.1161/hypertensionaha.109.133942] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Humphreys DT, Hynes CJ, Patel HR, Wei GH, Cannon L, Fatkin D, Suter CM, Clancy JL, Preiss T. Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function. PLoS One 2012;7:e30933. [PMID: 22319597 DOI: 10.1371/journal.pone.0030933] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
2 Peters T, Schroen B. Missing links in cardiology: long non-coding RNAs enter the arena. Pflugers Arch 2014;466:1177-87. [PMID: 24619481 DOI: 10.1007/s00424-014-1479-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
3 Lu C, Wang X, Ha T, Hu Y, Liu L, Zhang X, Yu H, Miao J, Kao R, Kalbfleisch J, Williams D, Li C. Attenuation of cardiac dysfunction and remodeling of myocardial infarction by microRNA-130a are mediated by suppression of PTEN and activation of PI3K dependent signaling. J Mol Cell Cardiol 2015;89:87-97. [PMID: 26458524 DOI: 10.1016/j.yjmcc.2015.10.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
4 Wang X, Ha T, Liu L, Zou J, Zhang X, Kalbfleisch J, Gao X, Williams D, Li C. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res 2013;97:432-42. [PMID: 23208587 DOI: 10.1093/cvr/cvs356] [Cited by in Crossref: 102] [Cited by in F6Publishing: 100] [Article Influence: 11.3] [Reference Citation Analysis]
5 Murakami K. Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genome. Curr Hypertens Rev 2015;11:80-90. [PMID: 25828869 DOI: 10.2174/1573402111666150401105317] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
6 Wang X, Ha T, Zou J, Ren D, Liu L, Zhang X, Kalbfleisch J, Gao X, Williams D, Li C. MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovasc Res 2014;102:385-95. [PMID: 24576954 DOI: 10.1093/cvr/cvu044] [Cited by in Crossref: 93] [Cited by in F6Publishing: 90] [Article Influence: 13.3] [Reference Citation Analysis]
7 Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L, Kalbfleisch JH, Gao X, Kao RL, Williams DL, Li C. Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression. J Immunol 2015;195:672-82. [PMID: 26048146 DOI: 10.4049/jimmunol.1403155] [Cited by in Crossref: 114] [Cited by in F6Publishing: 111] [Article Influence: 19.0] [Reference Citation Analysis]
8 Marques FZ, Campain AE, Tomaszewski M, Zukowska-Szczechowska E, Yang YH, Charchar FJ, Morris BJ. Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 2011;58:1093-8. [PMID: 22042811 DOI: 10.1161/HYPERTENSIONAHA.111.180729] [Cited by in Crossref: 155] [Cited by in F6Publishing: 103] [Article Influence: 15.5] [Reference Citation Analysis]
9 Ha T, Liu L, Kelley J, Kao R, Williams D, Li C. Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid Redox Signal. 2011;15:1875-1893. [PMID: 21091074 DOI: 10.1089/ars.2010.3723] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
10 Wu L, Chen Y, Chen Y, Yang W, Han Y, Lu L, Yang K, Cao J. Effect of HIF-1α/miR-10b-5p/PTEN on Hypoxia-Induced Cardiomyocyte Apoptosis. J Am Heart Assoc 2019;8:e011948. [PMID: 31480879 DOI: 10.1161/JAHA.119.011948] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
11 Celikbilek M, Baskol M, Taheri S, Deniz K, Dogan S, Zararsiz G, Gursoy S, Guven K, Ozbakır O, Dundar M, Yucesoy M. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol 2014; 6(8): 613-620 [PMID: 25232454 DOI: 10.4254/wjh.v6.i8.613] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
12 Wilker EH, Alexeeff SE, Suh H, Vokonas PS, Baccarelli A, Schwartz J. Ambient pollutants, polymorphisms associated with microRNA processing and adhesion molecules: the Normative Aging Study. Environ Health 2011;10:45. [PMID: 21600003 DOI: 10.1186/1476-069X-10-45] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
13 Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, Hasegawa K, Kita T, Kimura T. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway. Cardiovasc Res 2010;87:656-64. [PMID: 20495188 DOI: 10.1093/cvr/cvq148] [Cited by in Crossref: 139] [Cited by in F6Publishing: 132] [Article Influence: 12.6] [Reference Citation Analysis]
14 Zhao Z, He J, Zhang J, Liu M, Yang S, Li N, Li X. Dysregulated miR1254 and miR579 for cardiotoxicity in patients treated with bevacizumab in colorectal cancer. Tumour Biol 2014;35:5227-35. [PMID: 24515657 DOI: 10.1007/s13277-014-1679-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
15 Yang X, Li G, Yang T, Guan M, An N, Yang F, Dai Q, Zhong C, Luo C, Gao Y, Das S, Xing Y, Shang H. Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity. Oxid Med Cell Longev 2020;2020:4894625. [PMID: 33110473 DOI: 10.1155/2020/4894625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010;3:499-506. [PMID: 20921333 DOI: 10.1161/circgenetics.110.957415] [Cited by in Crossref: 504] [Cited by in F6Publishing: 279] [Article Influence: 45.8] [Reference Citation Analysis]
17 Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L, Kalbfleisch JH, Gao X, Kao RL, Williams DL. Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression. J Immunol. 2015;195:672-682. [PMID: 26048146 DOI: 19.4049/jimmunol.1403155] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Mateo Leach I, van der Harst P, de Boer RA. Pharmacoepigenetics in heart failure. Curr Heart Fail Rep 2010;7:83-90. [PMID: 20424992 DOI: 10.1007/s11897-010-0011-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
19 Zheng HW, Wang YL, Lin JX, Li N, Zhao XQ, Liu GF, Liu LP, Jiao Y, Gu WK, Wang DZ, Wang YJ. Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage. CNS Neurosci Ther 2012;18:1003-11. [PMID: 23190933 DOI: 10.1111/cns.12019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
20 Cheng Y, Zhang C. MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res 2010;3:251-5. [PMID: 20560046 DOI: 10.1007/s12265-010-9169-7] [Cited by in Crossref: 216] [Cited by in F6Publishing: 205] [Article Influence: 19.6] [Reference Citation Analysis]
21 van de Vrie M, Heymans S, Schroen B. MicroRNA involvement in immune activation during heart failure. Cardiovasc Drugs Ther 2011;25:161-70. [PMID: 21503626 DOI: 10.1007/s10557-011-6291-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]